Good morning, everyone, and welcome to another working week. We hope the weekend respite was somehow relaxing and invigorating, despite the high temperatures. But now that the predictable routine of phone calls, online meetings, and deadlines has returned, we will cool off with a cup of stimulation. Our choice today is salted caramel mocha. Please feel free to join us. As always, we have gathered a fresh bushel of interesting items for you to peruse as you start your own journey. We hope all goes well and this turns out to be a productive and meaningful day. And of course, do keep in touch. …
The Biden administration is preparing a sweeping initiative to develop a next generation of Covid-19 immunizations that would thwart future coronavirus variants and dramatically reduce rates of coronavirus infection or transmission, building on current shots whose impact has been mainly to prevent serious illness and death, STAT reports. To kick off the effort, the White House is gathering key federal officials, top scientists, and pharmaceutical executives including representatives of Pfizer and Moderna for a Tuesday “summit” to discuss the new technologies and lay out a road map for developing them.
An Indian court rejected bail pleas in a bribery case involving Biocon Biologics, a top official and an inspector from the Central Drugs Standard Control Organization, and an industry consultant, according to The Economic Times. The consultant was allegedly hired by Biocon to bribe officials at the regulator to win approvals, a charge the company denied. S Eswara Reddy, who heads the CDSCO and was arrested last month by the Central Bureau of Investigation for allegedly receiving a bribe, claimed he was falsely implicated as part of a larger conspiracy so that he does not become the next drug controller general of India.
Create a display name to comment
This name will appear with your comment